Clinical Trial Update: Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA [Phase 3]

View source ↗

Summary

Phase 3 trial comparing retapamulin to linezolid for staphylococcal skin infections including impetigo; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo
• Skin and Soft Tissue Infection

Drugs mentioned

• Linezolid (Zyvox) (linezolid)
• Retapamulin (Altabax) (retapamulin)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Skin Infections, Bacterial | Phase 3 | Status: COMPLETED | Results posted: 2011-08-26